J. Feldman

Stereotactic Body Radiotherapy for Early-Stage Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Endorsement of the American Society for Radiation Oncology Evidence-Based Guideline.

S. Jolly, S. Broderick, B. Meyers, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Comprehensive metastatic ablation in advanced NSCLC through biology-guided radiotherapy - A path forward?

S. Shirvani, K. Higgins, M. Garassino, 2021, Lung cancer.

Increasing Inclusiveness of Patient-Centric Clinical Evidence Generation in Oncology: Real-World Data and Clinical Trials.

Edward S. Kim, J. Lund, J. Benbow, 2022, American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting.

Prognostic communication about lung cancer in the precision oncology era: A multiple‐perspective qualitative study

L. Traeger, J. Temel, J. Greer, 2022, Cancer.

ESMO expert consensus statements on the management of EGFR mutant Non-Small Cell Lung Cancer.

P. Jänne, I. Wistuba, L. Sequist, 2022, Annals of oncology : official journal of the European Society for Medical Oncology.

Biosimilar switching – current state of knowledge

P. Wiland, J. Świerkot, B. Batko, 2018, Reumatologia.

The value of patient-reported outcomes in lung cancer clinical trials

C. Pompili, J. Feldman, 2022, JTCVS open.

Searching for Clinical Trials in Oncology: Finding a path through the Maze.

J. Feldman, A. Desai, V. Subbiah, 2023, Annals of oncology : official journal of the European Society for Medical Oncology.

EGFR Mutations Are Not All the Same: the Importance of Biomarker Testing in Non-small Cell Lung Cancer (NSCLC)—A Podcast Discussion Between Patients and Oncologists

S. Goldberg, J. Feldman, Stephen V Liu, 2023, Oncology and Therapy.

Treatment of Oligometastatic Non-Small Cell Lung Cancer: An ASTRO/ESTRO Clinical Practice Guideline.

P. Iyengar, M. Berry, D. de Ruysscher, 2023, Practical radiation oncology.